Evidence map›Paper›PMID 27006398›Full record

ArticleThe Journal of biological chemistry2016

Crystal Structure of Mycobacterium tuberculosis H37Rv AldR (Rv2779c), a Regulator of the ald Gene: DNA BINDING AND IDENTIFICATION OF SMALL MOLECULE INHIBITORS.

Abhishek Dey, Sonal Shree, Sarvesh Kumar Pandey, Rama Pati Tripathi, Ravishankar Ramachandran

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. The Lrp/AsnC-Type Regulator PA2577 Controls the EamA-like Transporter GeneInternational journal of molecular sciences · 2021
    Article
  4. Article
  5. Article
  6. Alanine dehydrogenases in mycobacteria.Journal of microbiology (Seoul, Korea) · 2019
    Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Abhishek DeyFrom the Molecular and Structural Biology Division and.
Sonal ShreeFrom the Molecular and Structural Biology Division and.
Sarvesh Kumar Pandeythe Medicinal and Process Chemistry Division, Council of Scientific and Industrial Research-Central Drug Research Institute, Jankipuram Extension, Sitapur Road, Lucknow, Uttar Pradesh 226031, India.
Rama Pati Tripathithe Medicinal and Process Chemistry Division, Council of Scientific and Industrial Research-Central Drug Research Institute, Jankipuram Extension, Sitapur Road, Lucknow, Uttar Pradesh 226031, India.
Ravishankar RamachandranFrom the Molecular and Structural Biology Division and r_ravishankar@cdri.res.in.
Central Drug Research Institute · IN

Funding

6 · The paper itself

Abstract

Here we report the crystal structure of M. tuberculosis AldR (Rv2779c) showing that the N-terminal DNA-binding domains are swapped, forming a dimer, and four dimers are assembled into an octamer through crystal symmetry. The C-terminal domain is involved in oligomeric interactions that stabilize the oligomer, and it contains the effector-binding sites. The latter sites are 30-60% larger compared with homologs like MtbFFRP (Rv3291c) and can consequently accommodate larger molecules. MtbAldR binds to the region upstream to the ald gene that is highly up-regulated in nutrient-starved tuberculosis models and codes for l-alanine dehydrogenase (MtbAld; Rv2780). Further, the MtbAldR-DNA complex is inhibited upon binding of Ala, Tyr, Trp and Asp to the protein. Studies involving a ligand-binding site G131T mutant show that the mutant forms a DNA complex that cannot be inhibited by adding the amino acids. Comparative studies suggest that binding of the amino acids changes the relative spatial disposition of the DNA-binding domains and thereby disrupt the protein-DNA complex. Finally, we identified small molecules, including a tetrahydroquinoline carbonitrile derivative (S010-0261), that inhibit the MtbAldR-DNA complex. The latter molecules represent the very first inhibitors of a feast/famine regulatory protein from any source and set the stage for exploring MtbAldR as a potential anti-tuberculosis target.

Indexed as

Alanine DehydrogenaseAmino AcidsBacterial ProteinsBinding SitesCircular DichroismCrystallography, X-RayGene Expression Regulation, BacterialModels, MolecularMycobacterium tuberculosisProtein BindingProtein DomainsProtein Structure, SecondaryRegulatory Sequences, Nucleic AcidSmall Molecule LibrariesTranscription FactorsAlanine DehydrogenaseAmino AcidsBacterial ProteinsSmall Molecule LibrariesTranscription FactorsAldRcrystal structureDNA binding proteinDNA-protein interactionenzyme inhibitorfeast/famine regulatory proteinsLrp/AsncMycobacterium tuberculosisoligomeric associationregulator

Identifiers

PMID27006398
PMCPMC4933250
OpenAlexW2304144432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.